GLP-1 And Alcohol Is Now A Trial, Not A Restaurant Anecdote
Semaglutide may reduce heavy drinking in a specific trial population, which is stronger and narrower than the viral story.
The news. The narrative. The timeline.
Bureau: Chicago
Semaglutide may reduce heavy drinking in a specific trial population, which is stronger and narrower than the viral story.
The hantavirus update belongs with clinicians and risk boundaries, not cruise panic.
The MV Hondius story moved from exotic cruise outbreak to the plain mechanics of docking, tracing, and disinfection.
A third year of falling overdose deaths is real progress, but the state map refuses a national victory lap.
The daraxonrasib news is not a general cancer promise but a narrow route for eligible pancreatic-cancer patients.
Sonrotoclax's accelerated approval matters most for the patients who have already crossed the BTK-treatment gate.
The spring outbreak is not exotic; it is in coop shoes, unwashed hands, small children, and eggs.
While the national measles argument burns, CDC's toolkit is the part parents and schools can actually use.